Elisa Agostinetto
LightNews LightNews
banner
elisaagostinetto.bsky.social
Elisa Agostinetto
@elisaagostinetto.bsky.social
430 followers 320 following 45 posts
Medical Oncologist and Researcher in Breast Cancer
📍Institut Jules Bordet, Brussels🇧🇪
Posts Replies Media Videos
Pinned
elisaagostinetto.bsky.social
Elisa Agostinetto @elisaagostinetto.bsky.social · Sep 17
I am thrilled to start the #ESMO Leadership Program 2025/26 with such an amazing class of colleagues from all over the world! 🌎
Truly honored for being selected for this prestigious program and looking forward to #ESMO25 to start this journey together🚀
@myesmo.bsky.social @oncoalert.bsky.social
Reposted by Elisa Agostinetto
oncoalert.bsky.social
Colleagues, the Complete #ESMO25 OncoAlert Newsletter is coming Oct 27‼️ GET IT HERE👉 oncoalert.m-pages.com/nhMpwe/oncoa...

50 of our PICKS of TOP Trials out of Berlin 🇩🇪
@elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @erikahamilton9.bsky.social @maryamlustberg.bsky.social
October 22, 2025 at 2:25 PM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
Oncology Here & NOW S2E3 in #BreastCancer
with @elisaagostinetto.bsky.social & @erikahamilton9.bsky.social discussing:

✅Current & emerging treatments
✅Patient selection
✅T-DXd + pertuzumab
✅ILD management & more
@hoperugo.bsky.social @elisabettabonzano.bsky.social
youtu.be/YdUX52c22Ig
Oncology Here and Now podcast (Breast Cancer) S02E03 w/ Dr. Erika Hamilton and Dr. Elisa Agostinetto
YouTube video by OncoAlert 360
youtu.be
October 6, 2025 at 2:06 PM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The OncoAlert Breast Cancer Faculty, led by Dr. Elisa Agostinetto🇧🇪 , has selected the OncoAlert🚨 TOP 🔟 #BreastCancer Abstracts to be presented at #ESMO25 in Berlin
September 30, 2025 at 11:42 AM
elisaagostinetto.bsky.social
I am thrilled to start the #ESMO Leadership Program 2025/26 with such an amazing class of colleagues from all over the world! 🌎
Truly honored for being selected for this prestigious program and looking forward to #ESMO25 to start this journey together🚀
@myesmo.bsky.social @oncoalert.bsky.social
September 17, 2025 at 8:52 AM
Reposted by Elisa Agostinetto
natrevcancer.nature.com
#ResearchHighlight

In a study published in #Cell, Phelps et al. find a mechanism connecting exercise, gut microbiota & anti-tumour immunity; exercise induces microbiota to produce formate, which in turn enhances CD8+ T cell functionality.

👇
No strain, no formate gains - Nature Reviews Cancer
In a study published in Cell, Phelps et al. find a mechanism connecting exercise, gut microbiota and anti-tumour immunity; exercise induces microbiota to produce formate, which in turn enhances CD8+ T cell functionality.
www.nature.com
August 5, 2025 at 2:40 PM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The OncoAlert WEEKLY RoundUp 🚨
Covering TOP of the week July 11-17
www.youtube.com/watch?v=N9lO...

REGISTER👉 www.OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...

@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@realbowtiedoc.bsky.social
@drnataliagandur.bsky.social
The OncoAlert 🚨Weekly Round Up July 11-17, 2025 (VIDEO)
YouTube video by OncoAlert 360
www.youtube.com
July 18, 2025 at 10:43 AM
Reposted by Elisa Agostinetto
cor2ed.com
📣Highlights from #ESMO Breast Cancer 2025 Satellite Symposium

Experts discuss treatment strategies/sequencing after ET+CDK4/6i for ER+/HER2- metastatic #breastcancer

cor2ed.com/n-connect/pr...

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only
ER+/HER2- metastatic breast cancer: Highlights from ESMO Breast Cancer 2025 Satellite Symposium | COR2ED
In this conference update video, Profs. Wolfgang Janni, Sherko Kümmel and Michail Ignatiadis provide key insights from the highly anticipated ESMO Breast
cor2ed.com
May 26, 2025 at 9:45 AM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The OncoAlert🚨NEWSLETTER
⭐️COMPLETE #ASCO25 EDITION

⭐️REGISTER
👉 oncoalert360.com
👉 buff.ly/48Xpgz0

@erikahamilton9.bsky.social
@drsgraff.bsky.social
@maryamlustberg.bsky.social
@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@drnataliagandur.bsky.social
@hoperugo.bsky.social
June 9, 2025 at 8:31 PM
Reposted by Elisa Agostinetto
europeancancer.bsky.social
ECO & IPOS bring you a powerful online roundtable exploring how empathy shapes cancer care, and how we can better support the professionals delivering it.

Join the discussion on 🗓️ Tuesday, 25 June at 🕓 16:00–17:30 CEST.

Register now 🔗 www.europeancancer.org/events/363:y...
June 5, 2025 at 10:45 AM
elisaagostinetto.bsky.social
Are you a young oncologist attending #ASCO25?

Join us on Monday, June 2 to talk about the Keys to Success for the Early Career Oncologist! 🔑 💫

Check here the sessions scheduled at the Trainee & Early Career Lounge: cdn.bfldr.com/KOIHB2Q3/as/...

@oncoalert.bsky.social
@ascocancer.bsky.social
May 29, 2025 at 7:02 AM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The #ASCO25 #OncoAlertTOP10 Abstracts in #BreastCancer
These are some of our picks of TOP abstracts we look forward to be presented at the upcoming ASCO Meeting in Chicago🇺🇸

@elisaagostinetto.bsky.social‬
@erikahamilton9.bsky.social‬
@drsgraff.bsky.social‬
@elisabettabonzano.bsky.social‬
May 23, 2025 at 10:05 AM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The OncoAlert🚨ROUND UP Now Out‼️
Covering May 15-22, 2025

REGISTER at oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...

youtu.be/xgIw0BISCpo

@elisaagostinetto.bsky.social
@barbaramelao.bsky.social
@elisaagostinetto.bsky.social
@icromeattini.bsky.social
@realbowtiedoc.bsky.social
The OncoAlert Oncology Round Up May 15-22, 2025 Top Oncology Breakthroughs in less than 5 Min!
YouTube video by OncoAlert 360
youtu.be
May 22, 2025 at 10:03 AM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The VJ OA Oncology Journal Club
Dr. Evandro de Azambuja discussing APHINITY in #BreastCancer now on APPLE PODCASTS

podcasts.apple.com/se/podcast/o...

@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@icromeattini.bsky.social
@maryamlustberg.bsky.social
VJ OA Oncology Journal Club: Final Results of the APHINITY Breast Cancer Trial Presented at ESMO Breast 2025
Poddavsnitt · OncoAlert · 2025-05-16 · 3 min
podcasts.apple.com
May 22, 2025 at 11:16 AM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The @OncoAlert 🚨 @VJOncology JOURNAL CLUB
Today we present @E_de_Azambuja 🇧🇪of @JulesBordet who talks to us about the Final Analysis of the APHINITY trial just Presented at #ESMOBreast25
youtu.be/ydcXe_faQH0

A sub analysis was just published out on European Journal of Cancer:
VJ OA Oncology Journal Club: Final Results of the APHINITY Breast Cancer Trial Presented at ESMO ...
Dr. Evandro de Azambuja discusses the final analysis of the APHINITY Breast Cancer trial just presented at ESMO Breast 2025.
youtu.be
May 16, 2025 at 10:13 AM
Reposted by Elisa Agostinetto
aftimosp.bsky.social
#ESMOBreast25 @laubdh.bsky.social from Institut Jules Bordet on the role of immunotherapy in ER+/HER2- early breast cancer #ESMOAmbassadors @myesmo.bsky.social
May 14, 2025 at 12:25 PM
elisaagostinetto.bsky.social
Right before the start of #ESMOBreast25, our last article is now out in #EJC

In this sub-analysis of the APHINITY trial led by @ChiaraDauccia, overweight/obesity was associated with poorer survival outcomes

50-days free access link👇🏻
authors.elsevier.com/a/1l5DL3QE--...

@oncoalert.bsky.social
authors.elsevier.com
May 13, 2025 at 7:00 PM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The OncoAlert🚨Newsletter Now Out Covering May 2-8, 2025

REGISTER at www.OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...

✅DESTINY-Breast11 Update from Industry
✅PEACE V STORM in #Prostate Cancer⛈️🕊️☢️
✅OS🧬EGFR-mutant Advanced🫁Non-Small Cell #LungCancer Treated with 1L Osimertinib
and more
May 8, 2025 at 2:55 PM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study

www.thelancet.com/journals/lan...

Findings provide robust evidence to guide counselling and management decisions for young BRCA carriers with prior breast cancer
May 8, 2025 at 6:14 AM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
NEWS FROM INDUSTRY🚨 Source AstraZeneca
DESTINY-Breast11 Update

DESTINY-Breast11 sees trastuzumab deruxtecan followed by paclitaxel, trastuzumab, and pertuzumab improved pathologic complete response rates compared to the standard neoadjuvant regimen

www.astrazeneca.com/media-centre...
May 7, 2025 at 8:59 AM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
Join @OncoAlert 🚨& @VJOncology Journal Club Discussing : Assisted reproductive technology in young BRCA carriers with a pregnancy after #BreastCancer

podcasts.apple.com/se/podcast/o...

@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
@realbowtiedoc.bsky.social
VJ/OA Oncology Journal Club (Breast Cancer): Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer with Dr. Magaton
Poddavsnitt · OncoAlert · 2025-05-02 · 5 min
podcasts.apple.com
May 6, 2025 at 7:48 AM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
Join Us at Oncology Here & Now
www.oncoalert360.com/12789765039p...

@elisaagostinetto.bsky.social @realbowtiedoc.bsky.social @biagioricciutimd.bsky.social @barbaramelao.bsky.social
@weoncologists.bsky.social @drsgraff.bsky.social @erikahamilton9.bsky.social
Oncology Here & Now Podcast
Introducing the OncoAlert Podcast, where oncology experts discuss the latest and most impactful research in the field. Tune in every 10 days for new episodes, each focusing on a different tumor type, ...
www.oncoalert360.com
May 2, 2025 at 4:57 PM
elisaagostinetto.bsky.social
I am so grateful that our work has been awarded with a #ConquerCancer #ASCO Merit Award! 💫
Proud to be on this list for the third time, a big thank goes to my mentors and co-authors - Looking forward to presenting our work in Chicago!🇧🇪✈️🇺🇸
@oncoalert.bsky.social
April 25, 2025 at 1:49 PM
elisaagostinetto.bsky.social
Extended adjuvant endocrine therapy for HR+/HER2-neg #breastcancer is a highly debated topic
Supporting the choice of prolonged treatment means balancing the QoL against the costs of toxicity
In this review we address this topic👇🏻
@oncoalert.bsky.social
www.sciencedirect.com/science/arti...
April 24, 2025 at 1:16 PM
Reposted by Elisa Agostinetto
oncoalert.bsky.social
The OncoAlert🚨Weekly Round Up Covering the TOP of the week April 4-10, 2025
REGISTER at oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...

youtu.be/l_jcTe69cCs

@elisaagostinetto.bsky.social
@elisabettabonzano.bsky.social
The OncoAlert Weekly Round Up April 3-10, 2025
Dear Colleagues,Welcome to the OncoAlert Weekly Round up Covering the TOP News and Trials THIS WEEK in Oncology. This week:Prognostic implications of risk de...
youtu.be
April 11, 2025 at 10:31 AM
Reposted by Elisa Agostinetto
bigxresearch.bsky.social
The #AURORA Data Analysis Committee is in Florence for a “datathon”! Over the next 2 days, PIs, bioinformaticians, clinicians, and BIG HQ are working together on analyses to advance a new AURORA manuscript. @aftimosp.bsky.social
@elisaagostinetto.bsky.social
April 10, 2025 at 11:13 AM